St. Jude Medical Inc has reached a $39.25 million class action settlement with shareholders to resolve claims it downplayed the possible dangers associated with a product used to connect implantable defibrillators to patients’ hearts. The preliminary settlement, disclosed Thursday with the U.S. District Court in Minneapolis, requires a judge’s approval. It resolves claims that St. Jude inflated …